The application OACs was associated with reduced hospital mortality and mechanical ventilation requirement in COVID-19 patients. Besides, antithrombotic treatment was associated with a reduction in in-hospital mortality among critically ill COVID-19 patients who required mechanical ventilation.
Keyphrases
- mechanical ventilation
- sars cov
- acute respiratory distress syndrome
- intensive care unit
- coronavirus disease
- respiratory failure
- cardiovascular events
- end stage renal disease
- atrial fibrillation
- ejection fraction
- newly diagnosed
- extracorporeal membrane oxygenation
- healthcare
- risk factors
- type diabetes
- stem cells
- respiratory syndrome coronavirus
- mesenchymal stem cells
- patient reported outcomes
- coronary artery disease
- replacement therapy
- combination therapy